These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 1322857)

  • 1. [Affinity of Z-105 to the 1,4-dihydropyridine type calcium channel and several other receptor bindings in the central nervous system].
    Niwa M; Nozaki M; Kobayashi M; Tsurumi K
    Nihon Yakurigaku Zasshi; 1992 Jul; 100(1):59-66. PubMed ID: 1322857
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis of 1,4-dihydropyridine-5-phosphonates and their calcium-antagonistic and antihypertensive activities: novel calcium-antagonist 2-[benzyl(phenyl)amino]ethyl 5-(5,5-dimethyl-2-oxo-1,3,2-dioxaphosphorinan-2-yl)-1,4-dihydro-2,6-dim ethyl-4-(3-nitrophenyl)-3-pyridinecarboxylate hydrochloride ethanol (NZ-105) and its crystal structure.
    Sakoda R; Kamikawaji Y; Seto K
    Chem Pharm Bull (Tokyo); 1992 Sep; 40(9):2362-9. PubMed ID: 1446356
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and crystal structure of optically active 2-[benzyl(phenyl)amino]ethyl 5-(5,5-dimethyl-2-oxo-1,3,2-dioxaphosphorinan-2-yl)-1,4-dihydro-2,6-dim ethyl-4-(3-nitrophenyl)-3-pyridinecarboxylate (NZ-105).
    Sakoda R; Matsumoto H; Seto K
    Chem Pharm Bull (Tokyo); 1992 Sep; 40(9):2377-81. PubMed ID: 1446358
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NZ-105, a new 1,4-dihydropyridine derivative: correlation between dihydropyridine receptor binding and inhibition of calcium uptake in rabbit aorta.
    Yamashita T; Masuda Y; Sakai T; Tanaka S; Kasuya Y
    Jpn J Pharmacol; 1991 Nov; 57(3):337-48. PubMed ID: 1667534
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of dihydropyridine calcium channel blocking drugs on rat brain muscarinic and alpha-adrenergic receptors.
    Thayer SA; Welcome M; Chhabra A; Fairhurst AS
    Biochem Pharmacol; 1985 Jan; 34(2):175-80. PubMed ID: 2981533
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiac and vascular effects of NZ-105, a novel dihydropyridine derivative, in vitro.
    Masuda Y; Iwama T; Yamashita T; Sakai T; Hibi M; Tanaka S; Shigenobu K; Kasuya Y
    Arch Int Pharmacodyn Ther; 1991; 314():57-73. PubMed ID: 1668604
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vasorelaxing and receptor binding properties of NZ-105, a novel dihydropyridine derivative, in isolated rabbit aorta.
    Masuda Y; Iwama T; Yamashita T; Sakai T; Hibi M; Tanaka S; Shigenobu K; Kasuya Y
    Arch Int Pharmacodyn Ther; 1991; 312():86-103. PubMed ID: 1663336
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A new Ca-antagonist, CD-349, binding to the Ca-channel of rat myocardium and brain and hog coronary artery.
    Muramatsu M; Fujita-Tominaga A; Tanaka M; Ishii Y; Aihara H
    Jpn J Pharmacol; 1988 Dec; 48(4):453-62. PubMed ID: 2854176
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms underlying the slow onset of action of a new dihydropyridine, NZ-105, on a cultured smooth muscle cell line.
    Tamura T; Saigusa A; Kokubun S
    Naunyn Schmiedebergs Arch Pharmacol; 1991 Apr; 343(4):405-10. PubMed ID: 1649411
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Photoaffinity labelling of the cardiac calcium channel. (-)-[3H]azidopine labels a 165 kDa polypeptide, and evidence against a [3H]-1,4-dihydropyridine-isothiocyanate being a calcium-channel-specific affinity ligand.
    Ferry DR; Goll A; Glossmann H
    Biochem J; 1987 Apr; 243(1):127-35. PubMed ID: 2440422
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of efonidipine, nicardipine and captopril on proteinuria in aged spontaneously hypertensive rats.
    Shudo C; Masuda Y; Sugita H; Tamura T; Furukawa S; Hayashi K; Hirata H; Shikada K; Tanaka S; Tomita K
    Arzneimittelforschung; 1996 Sep; 46(9):852-4. PubMed ID: 8876932
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo characterization of combination antitumor chemotherapy with calcium channel blockers and cis-diamminedichloroplatinum(II).
    Onoda JM; Nelson KK; Taylor JD; Honn KV
    Cancer Res; 1989 Jun; 49(11):2844-50. PubMed ID: 2720644
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of efonidipine hydrochloride (NZ-105), a new dihydropyridine calcium antagonist, on the experimental atherosclerosis in cholesterol-fed rabbits].
    Toyoda K; Kitahara M; Yamashita T; Shudo C; Masuda Y; Sakashita M; Tanaka S; Saito Y
    Nihon Yakurigaku Zasshi; 1994 May; 103(5):231-9. PubMed ID: 8188119
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure-activity relationships of receptor binding of 1,4-dihydropyridine derivatives.
    Takahashi D; Oyunzul L; Onoue S; Ito Y; Uchida S; Simsek R; Gunduz MG; Safak C; Yamada S
    Biol Pharm Bull; 2008 Mar; 31(3):473-9. PubMed ID: 18310913
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of efonidipine hydrochloride metabolites in rats.
    Nakabeppu H; Nakajima A; Kamikawaji Y; Shinozaki Y
    Arzneimittelforschung; 1995 Jul; 45(7):766-70. PubMed ID: 8573219
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of the new calcium antagonist efonidipine hydrochloride on resting and exercise hemodynamics in patients with stable effort angina.
    Saito T; Fujii K; Takizawa T; Toyosaki T; Kuwabara Y; Kobayashi S; Ichikawa H; Karaki A; Yamazaki Y; Iwata J; Yamada K; Tomiya H; Takeda K; Inagaki Y
    Arzneimittelforschung; 1996 Sep; 46(9):861-7. PubMed ID: 8876934
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Binding of the dihydropyridine calcium channel blocker (+)-[3H] isopropyl-4-(2,1,3-benzoxadiazol-4-yl)-1,4-dihydro-5-methoxycarbonyl-2, 6-dimethyl-3-pyridinecarboxylate (PN200-110) to RINm5F membranes and cells: characterization and functional significance.
    Yaney GC; Stafford GA; Henstenberg JD; Sharp GW; Weiland GA
    J Pharmacol Exp Ther; 1991 Aug; 258(2):652-62. PubMed ID: 1713965
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unaltered hippocampal dihydropyridine and omega-conotoxin GVIA binding sites after repeated electroconvulsive shock in rats.
    Dooley DJ
    Biol Psychiatry; 1992 Jul; 32(2):188-90. PubMed ID: 1330008
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of a dihydropyridine analogue, 2-[benzyl(phenyl)amino]ethyl 1,4-dihydro-2,6-dimethyl-5-(5,5-dimethyl-2-oxo- 1,3,2-dioxaphosphorinan-2-yl)-1-(2-morpholinoethyl)-4-(3-nitrophenyl)-3 -pyridinecarboxylate on reversing in vivo resistance of tumor cells to adriamycin.
    Niwa K; Yamada K; Furukawa T; Shudo N; Seto K; Matsumoto T; Takao S; Akiyama S; Shimazu H
    Cancer Res; 1992 Jul; 52(13):3655-60. PubMed ID: 1617639
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiovascular selectivity of 1,4-dihydropyridine derivatives, efonidipine (NZ-105), nicardipine and structure related compounds in isolated guinea-pig tissues.
    Masuda Y; Miyajima M; Shudo C; Tanaka S; Shigenobu K; Kasuya Y
    Gen Pharmacol; 1995 Mar; 26(2):339-45. PubMed ID: 7590084
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.